• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和验证一种测定极低胎龄新生儿干血斑中布地奈德含量的方法。

Development and validation of an assay for quantifying budesonide in dried blood spots collected from extremely low gestational age neonates.

机构信息

Division of Clinical Pharmacology, Department of Pediatrics, School of Medicine, University of Utah, Salt Lake City, UT, United States; Department of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, United States.

Center for Human Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, United States.

出版信息

J Pharm Biomed Anal. 2019 Apr 15;167:7-14. doi: 10.1016/j.jpba.2019.01.048. Epub 2019 Jan 29.

DOI:10.1016/j.jpba.2019.01.048
PMID:30738243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7233423/
Abstract

Budesonide is a potential therapeutic option for the prevention of bronchopulmonary dysplasia in mechanically ventilated premature neonates. The dose and concentrations of budesonide that drive effective prophylaxis are unknown, due in part to the difficulty in obtaining serial blood samples from this fragile population. Of primary concern is the limited total blood volume available for collection for the purposes of a pharmacokinetic study. Dried blood spots (DBS), which require the collection of <200 μL whole blood to fill an entire card, are an attractive low-blood volume alternative to traditional venipuncture sampling. We describe a simple and sensitive method for determining budesonide concentrations in DBS using an ultra-high-performance liquid chromatography - tandem mass spectrometry assay. Budesonide was liberated from a single 6 mm punch using a basified methyl tert-butyl ether extraction procedure. The assay was determined to be accurate and precise in the dynamic range of 1 to 50 ng/mL. The validated assay was then successfully applied to DBS collected as part of a multi-center, dose-escalation study of budesonide administered in surfactant via intra-tracheal instillation to premature neonates between 23 and 28 weeks gestational age. These findings show that DBS are a useful technique for collecting pharmacokinetic samples in premature neonates and other pediatric populations.

摘要

布地奈德是机械通气早产儿预防支气管肺发育不良的一种潜在治疗选择。由于从这个脆弱的人群中获得连续的血样存在困难,因此,驱动有效预防的布地奈德剂量和浓度尚不清楚。主要关注的问题是,为药代动力学研究收集的总血容量有限。干血斑(DBS),需要采集<200μL 的全血才能填满整个卡片,是一种有吸引力的低血量替代传统静脉穿刺采样的方法。我们描述了一种使用超高效液相色谱-串联质谱分析测定 DBS 中布地奈德浓度的简单灵敏方法。使用碱性甲基叔丁基醚提取程序从单个 6mm 冲头中释放布地奈德。该测定法在 1 至 50ng/mL 的动态范围内具有准确性和精密度。然后,该验证后的测定法成功地应用于 DBS 的采集,这些 DBS 是通过气管内滴注表面活性剂给予布地奈德的多中心剂量递增研究的一部分,纳入了 23 至 28 周胎龄的早产儿。这些发现表明,DBS 是在早产儿和其他儿科人群中采集药代动力学样本的有用技术。

相似文献

1
Development and validation of an assay for quantifying budesonide in dried blood spots collected from extremely low gestational age neonates.开发和验证一种测定极低胎龄新生儿干血斑中布地奈德含量的方法。
J Pharm Biomed Anal. 2019 Apr 15;167:7-14. doi: 10.1016/j.jpba.2019.01.048. Epub 2019 Jan 29.
2
"Center punch" and "whole spot" bioanalysis of apixaban in human dried blood spot samples by UHPLC-MS/MS.通过超高效液相色谱-串联质谱法对人干血斑样本中的阿哌沙班进行“中心打孔”和“全点”生物分析。
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Apr 15;988:66-74. doi: 10.1016/j.jchromb.2015.02.023. Epub 2015 Feb 21.
3
Quantitative determination of atenolol in dried blood spot samples by LC-HRMS: a potential method for assessing medication adherence.采用 LC-HRMS 对干血斑样本中的阿替洛尔进行定量测定:评估用药依从性的潜在方法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 May 15;897:72-9. doi: 10.1016/j.jchromb.2012.04.013. Epub 2012 Apr 16.
4
Application of automated serial blood sampling and dried blood spot technique with liquid chromatography-tandem mass spectrometry for pharmacokinetic studies in mice.应用自动化连续采血和液相色谱-串联质谱法的干血斑技术进行小鼠药代动力学研究。
J Pharm Biomed Anal. 2011 Nov 1;56(3):604-8. doi: 10.1016/j.jpba.2011.06.022. Epub 2011 Jul 1.
5
Dried blood spots as a sampling technique for the quantitative determination of guanfacine in clinical studies.干血斑作为临床研究中胍法辛定量测定的一种采样技术。
Bioanalysis. 2011 Nov;3(22):2501-14. doi: 10.4155/bio.11.262.
6
Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole.手动打孔与自动化流动式干血斑 LC-MS/MS 分析伏立康唑样品解吸的比较。
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jul 1;1089:16-23. doi: 10.1016/j.jchromb.2018.04.039. Epub 2018 Apr 27.
7
Validated HPLC method for ceftriaxone from dried blood spots for pharmacokinetic studies and therapeutic drug monitoring in neonatal population.用于新生儿群体药代动力学研究和治疗药物监测的干血斑中头孢曲松的验证 HPLC 方法。
Bioanalysis. 2023 Apr;15(8):449-463. doi: 10.4155/bio-2023-0047. Epub 2023 May 22.
8
Evaluation of dried blood spot (DBS) technology versus plasma analysis for the determination of MK-1775 by HILIC-MS/MS in support of clinical studies.评估干血斑(DBS)技术与血浆分析在支持临床研究的 HILIC-MS/MS 测定 MK-1775 中的应用。
Anal Bioanal Chem. 2012 Dec;404(10):3037-48. doi: 10.1007/s00216-012-6440-6. Epub 2012 Oct 26.
9
Analytical and clinical validation of a dried blood spot assay for the determination of paclitaxel using high-performance liquid chromatography-tandem mass spectrometry.一种采用高效液相色谱-串联质谱法测定紫杉醇的干血斑分析方法的分析及临床验证
Clin Biochem. 2018 Apr;54:123-130. doi: 10.1016/j.clinbiochem.2018.02.020. Epub 2018 Mar 4.
10
Development and validation of an analytical method using UPLC-MS/MS to quantify everolimus in dried blood spots in the oncology setting.开发和验证一种使用 UPLC-MS/MS 定量检测肿瘤环境中干血斑中依维莫司的分析方法。
J Pharm Biomed Anal. 2018 Feb 5;149:106-113. doi: 10.1016/j.jpba.2017.10.039. Epub 2017 Oct 29.

引用本文的文献

1
The Modulation of Cell Plasticity by Budesonide: Beyond the Metabolic and Anti-Inflammatory Actions of Glucocorticoids.布地奈德对细胞可塑性的调节作用:超越糖皮质激素的代谢和抗炎作用
Pharmaceutics. 2025 Apr 11;17(4):504. doi: 10.3390/pharmaceutics17040504.
2
Use of Antibiotics in Preterm Newborns.早产儿抗生素的使用
Antibiotics (Basel). 2022 Aug 23;11(9):1142. doi: 10.3390/antibiotics11091142.
3
Challenges in conducting paediatric trials with off-patent drugs.开展非专利药物儿科试验面临的挑战。
Contemp Clin Trials Commun. 2021 Jun 21;23:100783. doi: 10.1016/j.conctc.2021.100783. eCollection 2021 Sep.
4
Intra-tracheal surfactant/budesonide versus surfactant alone: Comparison of two consecutive cohorts of extremely preterm infants.气管内表面活性物质/布地奈德与单独使用表面活性物质:两批极早产儿的连续队列比较。
Pediatr Pulmonol. 2021 Jul;56(7):2114-2124. doi: 10.1002/ppul.25415. Epub 2021 May 4.
5
Quantitative microsampling for bioanalytical applications related to the SARS-CoV-2 pandemic: Usefulness, benefits and pitfalls.定量微采样在与 SARS-CoV-2 大流行相关的生物分析应用中的应用:有用性、益处和陷阱。
J Pharm Biomed Anal. 2020 Nov 30;191:113597. doi: 10.1016/j.jpba.2020.113597. Epub 2020 Aug 30.
6
Therapeutic Drug Monitoring Is a Feasible Tool to Personalize Drug Administration in Neonates Using New Techniques: An Overview on the Pharmacokinetics and Pharmacodynamics in Neonatal Age.治疗药物监测是一种可行的工具,可用于使用新技术个性化新生儿的药物管理:新生儿期药代动力学和药效学概述。
Int J Mol Sci. 2020 Aug 17;21(16):5898. doi: 10.3390/ijms21165898.
7
Simultaneous determination of cardiovascular drugs in dried blood spot by liquid chromatography-tandem mass spectrometry.液相色谱-串联质谱法同时测定干血斑中的心血管药物。
J Food Drug Anal. 2019 Oct;27(4):906-914. doi: 10.1016/j.jfda.2019.06.001. Epub 2019 Jun 26.

本文引用的文献

1
Dried Blood Spot Reference Intervals for Steroids and Amino Acids in a Neonatal Cohort of the National Children's Study.《全国儿童研究中新生儿队列的类固醇和氨基酸的干血斑参考区间》
Clin Chem. 2016 Dec;62(12):1658-1667. doi: 10.1373/clinchem.2016.263434. Epub 2016 Oct 26.
2
Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia.经气管内给予布地奈德/表面活性物质预防支气管肺发育不良。
Am J Respir Crit Care Med. 2016 Jan 1;193(1):86-95. doi: 10.1164/rccm.201505-0861OC.
3
The use of mass spectrometry to analyze dried blood spots.利用质谱分析法分析干血斑。
Mass Spectrom Rev. 2016 May-Jun;35(3):361-438. doi: 10.1002/mas.21441. Epub 2014 Sep 22.
4
Phospholipid removal combined with a semi-automated 96-well SPE application for determination of budesonide in human plasma with LC-MS/MS.磷脂去除结合半自动96孔固相萃取应用于液相色谱-串联质谱法测定人血浆中的布地奈德。
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Nov 1;970:31-5. doi: 10.1016/j.jchromb.2014.08.035. Epub 2014 Sep 6.
5
Therapeutic drug monitoring by dried blood spot: progress to date and future directions.干血斑治疗药物监测:迄今进展与未来方向
Clin Pharmacokinet. 2014 Nov;53(11):961-73. doi: 10.1007/s40262-014-0177-7.
6
Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.支气管肺发育不良:NHLBI 慢性肺部疾病初级预防研讨会。
Ann Am Thorac Soc. 2014 Apr;11 Suppl 3(Suppl 3):S146-53. doi: 10.1513/AnnalsATS.201312-424LD.
7
Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer.采用台式四极杆/轨道阱质谱仪对干血斑(DBS)中禁用药物进行灵敏检测以用于兴奋剂控制。
Anal Bioanal Chem. 2012 May;403(5):1279-89. doi: 10.1007/s00216-011-5655-2. Epub 2012 Jan 10.
8
Compilation of 222 drugs' plasma protein binding data and guidance for study designs.222 种药物的血浆蛋白结合数据汇编及研究设计指南。
Drug Discov Today. 2012 May;17(9-10):475-85. doi: 10.1016/j.drudis.2011.12.018. Epub 2011 Dec 23.
9
Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.预测极早产儿支气管肺发育不良的出生后年龄。
Am J Respir Crit Care Med. 2011 Jun 15;183(12):1715-22. doi: 10.1164/rccm.201101-0055OC. Epub 2011 Mar 4.
10
Budesonide quantification by HPLC coupled to atmospheric pressure photoionization (APPI) tandem mass spectrometry. Application to a comparative systemic bioavailability of two budesonide formulations in healthy volunteers.采用高效液相色谱-大气压光电离(APPI)串联质谱法对布地奈德进行定量分析。应用于两种布地奈德制剂在健康志愿者中的比较系统生物利用度。
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Feb 1;879(3-4):236-42. doi: 10.1016/j.jchromb.2010.12.003. Epub 2010 Dec 13.